{"id":1878,"date":"2017-09-29T16:49:00","date_gmt":"2017-09-29T14:49:00","guid":{"rendered":"https:\/\/www.optimhal-protecsom.com\/en\/?p=1878"},"modified":"2019-05-21T11:48:19","modified_gmt":"2019-05-21T09:48:19","slug":"the-galien-medstartup-awards-protecsom-optimhal-nominee-in-two-categories","status":"publish","type":"post","link":"https:\/\/www.optimhal-protecsom.com\/en\/blog\/the-galien-medstartup-awards-protecsom-optimhal-nominee-in-two-categories\/","title":{"rendered":"The Galien \u2013 MedStartUp Awards: ProtecSom OptimHal nominee in two categories"},"content":{"rendered":"

The Galien foundation, a true catalyst for the development of health technologies, pairs every year with Business France to encourage, recognize and reward transatlantic partnerships projects.<\/strong><\/p>

\"\"\"\"<\/p>

ProtecSom-OptimHal a finalist in two categories<\/span><\/strong><\/span><\/h3>\n

Since 2014, the MedStartUp Awards<\/a> honour innovation, scientific excellence, and commercial potential of French-American projects. Preselected in 2016, the Laboratoire ProtecSom-OptimHal\u2019s project is the only one to be selected as one of the 3 finalists in two categories:<\/p>\n

\u00a0<\/p>\n